ArticleDisease markers2018

Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer.

Luca Reggiani Bonetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.